With interdisciplinary training in Life Sciences, Public Health, and Public Administration, Dr. Michael G. Tyshenko specializes in health risk communication and policy. He collaborates globally on infectious disease research, including SARS, MERS, and COVID-19, and leads chemical peer reviews at Risk Sciences International (RSI). His work also extends to pandemic planning in Nepal, focusing on drone delivery of medical supplies to remote areas. Tyshenko's expertise is sought by various government departments in Canada and abroad.

Dr. Calvin Willhite is a renowned expert in developmental toxicology and quantitative structure-activity relationships, with a substantial publication record. He has played key roles in influential organizations and committees, including the National Academy's Committee on Toxicology, the U.S. EPA's National Advisory Committee, and the IARC Cancer Chemoprevention Panel. Dr. Willhite is a member of the Society of Toxicology and is featured in notable biographical publications. Currently, he serves as an Associate Expert with Risk Sciences International, contributing to health risk assessments for various chemicals, both man-made and naturally-occurring.

Martin LeBlanc specializes in business development at RSI, focusing on client needs across various sectors including health, nuclear, and aerospace. With a background in electrical/mechanical technology and sales, he excels in assembling project teams and navigating complex procurement processes. He is adept at contract negotiation, proposal development, and is well-versed in Government of Canada procurement vehicles. Martin is also experienced in international projects and adapts quickly to new procurement processes.

Don Mattison's career is an amalgamation of medicine, science, and public service. He started with a Bachelor's degree in Chemistry and Mathematics, followed by a Master's from MIT in Chemistry. He then pivoted to medicine, obtaining an MD from Columbia University and focusing on pharmacology and toxicology in reproductive health during his residencies. Mattison has held several prestigious appointments, including Dean of the University of Pittsburgh's Graduate School of Public Health and Chief Medical Officer at Risk Sciences International. Throughout his career, he obtained medical licenses in six U.S. states and served in the U.S. Public Health Service, retiring with the rank of Captain. Most recently, he became a Distinguished Professor of Epidemiology at the University of South Carolina.

Dr. Nataliya Karyakina brings extensive expertise in toxicology and risk assessment to RSI. With a Ph.D. in Toxicology and experience at the McLaughlin Centre for Population Health Risk Assessment, she specializes in evaluating health risks from exposure to various toxic agents. Her research spans essential and toxic metals, pharmaceuticals, and nanomaterials. She has contributed to projects on chemical classification and labeling, as well as health-based regulatory guidance. Currently, she focuses on the health effects of engineered nanoalumina and diagnostic criteria for occupational manganism.

Excerpt: Andrew Maw, an Associate Expert at Risk Sciences International (RSI), specializes in digital service delivery, data-driven risk modeling, and regulatory transformation. With extensive experience as a senior executive in the Canadian federal public service, he helps clients transition to risk-based compliance models, leveraging advanced analytics, machine learning, and business transformation strategies to enhance decision-making and operational effectiveness.

Since 2002, Mr. McNair has led key aspects of Cerner's Big Data operations, ensuring data quality for over 700 healthcare institutions. His role focuses on using this data for predictive models and decision-support solutions. McNair's career at Cerner began in 1986, where he co-invented Discern Expert®, a real-time decision-support engine used globally. He held positions in regulatory affairs, served as a General Manager, and worked in pharmaceutical roles. McNair is a prominent figure in mathematical modeling, AI, and health finance, with over 100 patents and numerous publications. He's also active in volunteer work and academic pursuits.

Dr. Patricia Larkin's career is dedicated to policy and regulatory assessments, focusing on the intersection of social determinants of health and health equity. Her expertise lies in managing human health and environmental risks, particularly in energy, water resources, and climate change. Patricia's research explores Canadian innovation in energy regulatory decision-making and its impact on risk management. She has led interdisciplinary international research projects, addressing risk management in public decision-making and environmental issues like carbon capture and storage. As Chair of the Applied Risk Management Specialty Group of the Society for Risk Analysis, she continues to contribute to this field.

Dr. Cote boasts over 35 years of expertise in public health risk assessment and environmental management. She advises governments and industries on chemical exposure risks and risk assessment implementation. An adjunct professor at the University of Colorado, she educates on environmental health, risk assessment, and public policy. Dr. Cote also teaches risk assessment at Rutgers University. Her research focuses on cancer, respiratory diseases, and enhancing risk assessment methods. She spent 27 years at the US Environmental Protection Agency, serving in roles like Senior Science Advisor, Division Director, and Associate Laboratory Director. Dr. Cote's influence extends globally, advising organizations like the World Health Organization and the National Institutes of Health.

With 45 years of experience in exposure and risk assessment, Dr. Paul Price has worked with diverse organizations, including the U.S. EPA and Dow Chemical. Specializing in mixture risk assessments, he is an adjunct professor at the University of Iowa and serves on the European Food Safety Authority’s committee on combined exposures. A prolific author, Dr. Price is currently focused on publications concerning mixture risk assessment and the Mixture Adjustment Factor.